Analyst Research Report Snapshot

Title:

Active Biotech AB

Price:

$50.00

Provider:

MarketLine (a Datamonitor Company)

Date:

17 Dec 2014

Pages:

37

Type:

AcrobatPDF

Companies referenced:

ACTI.ST

Available for Immediate Download
Summary:

Active Biotech AB - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Active Biotech AB required for business and competitor intelligence needs - Intelligence on Active Biotech AB’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Active Biotech AB, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Active Biotech is engaged in the development of pharmaceuticals and vaccines for cancer, autoimmune and inflammatory diseases. The company's products under development include Laquinimod for the treatment of autoimmune diseases; Tasquinimod (TASQ) for prostate cancer; Paquinimod, for treatment of systemic Sclerosisand; and ANYARA for use in cancer targeted therapy, primarily of renal cell cancer. Active Biotech primarily operates in Sweden, where it is headquartered in Lund, and employs around 60 people. The company recorded revenues of SEK227.9 million (approximately $33.7 million) in the fiscal year ended December 2012, a decrease of 2.8% compared to 2011. The company's operating loss was SEK163.2 million (approximately $24.1 million) in fiscal 2012, as compared to an operating loss of SEK100.9 million (approximately $14.9million) in 2011. Its net loss was SEK175 million (approximately $25.9 million) in fiscal 2012, as compared to the net loss of SEK94.6 million (approximately $14 million) in 2011. Reasons to Purchase: - Gain understanding of Active Biotech AB the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Active Biotech AB as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Active Biotech AB your competitors' business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.